Xylem Sees Q4 Adj EPS $1.39-$1.44 vs $1.63 Est; Sees Sales $2.300B vs $2.446B Est
Benzinga Newsdesk 6 days ago
NewsGuidance
Xylem (NYSE:XYL) is looking for Q4 Adj EPS of $1.39-$1.44 vs $1.63 analyst estimate. sees sales of $2.300 billion vs $2.446 billion analyst estimate.
Xylem (NYSE:XYL) is looking for Q4 Adj EPS of $1.39-$1.44 vs $1.63 analyst estimate. sees sales of $2.300 billion vs $2.446 billion analyst estimate.